Objective: Morning blood pressure surge (MBPS) is an independent predictor of cardiovascular events. However, little is known on the association between glycemic control and MBPS and its effect on vascular injury in patients with type 2 diabetes mellitus (T2DM).
Introduction
Patients with diabetes mellitus (DM) tend to exhibit accelerated arteriosclerosis and are consequently at higher risk of cardiovascular disease (CVD), including stroke and coronary heart disease (1) . DM is often complicated with other co-morbidities that contribute to increased risk of CVD, i.e., hypertension, chronic kidney disease (CKD), and hyperlipidemia.
It has been increasingly recognized that the early morning blood pressure surge (MBPS), i.e., the increase in BP that occurs during the period from night to the early morning, which can be detected by ambulatory BP monitoring (ABPM), provides a clinically relevant measure to predict CVD risk, independent of age and 24-hour systolic blood pressure (24-h SBP) (2) . This concept is supported by data indicating that cerebral and cardiac events occur most often in the morning (3) . It is possible that inadequate glycemic control (4) or the occurrence of insulin resistance (5) activate sympathetic activity, which leads to MBPS in DM patients. Furthermore, hypertensive patients with exaggerated MBPS exhibit elevated levels of macrophages, T-lymphocytes, and tumor necrosis factor alpha in atherosclerotic plaques from the carotid artery compared with those without, suggesting an association between MBPS and vascular injury in hypertensive patients (6) . Taken together, these results suggest that poor glycemic control could accelerate vascular injury in DM patients by causing MBPS.
In this study, we evaluated (i) the association of insulin resistance and glycemic control with MBPS, and (ii) the association between MBPS and vascular endothelial dysfunction, as assessed by endothelium-dependent flow-mediated dilatation (FMD) and nitroglycerinmediated dilation (NMD), in type 2 DM patients.
Subjects and Methods

Subjects and design
The study protocol was approved by the Ethics Committee of Osaka City University Graduate School of Medicine; registration number 1857. This study was performed between October 2011 and November 2012. Written informed consent was obtained from each patient. Patients with type 2 DM (n=50), who participated in DM educational and/or complication-check programs in our university, were consecutively enrolled in this study.
The diagnosis of type 2 DM was made on the basis of a history of DM or according to the Japan Diabetes Society criteria (7) . The subjects were excluded if they exhibited renal dysfunction (estimated glomerular filtration rate (eGFR) ≤ 60ml/min./1. BP measurements and analysis of ABPM data Noninvasive ABPM was performed in a hospital setting with an automated system (TM2431; A&D, Tokyo, Japan) that records BP using the oscillometric method, and pulse rate every 30 min for 24h, as described previously (8) . Awake and sleep time were defined on the basis of written diaries recorded by the patients during the ABPM. The morning BP was defined as the average of the four BP values obtained during the first 2h after waking up. The lowest BP was defined as the average of the three BP readings centered around the lowest nighttime reading (i.e., the lowest nighttime reading plus the readings immediately before and after). The MBPS was calculated as the morning SBP minus the lowest SBP, as reported previously (9) .
Measurement of FMD and NMD using a novel ultrasounds system Endothelium-dependent FMD and endothelium-independent NMD were assessed according to the international guidelines (10) . The subjects did not smoke, eat, or drink anything containing caffeine for 12 hr before the FMD measurement. FMD was measured between 9 and 10 a.m. before the patient took any medications.
FMD was assessed in the right arm using a high-resolution ultrasound device (UNEXEF; UNEX Corporation, Nagoya, Japan), as described previously (11) . A 5 cm transverse section of the brachial artery was recorded for intervals of 30 sec at baseline and during peak reactive hyperemia (after deflation of the blood pressure cuff, which had previously been inflated to 50 mmHg above the systolic blood pressure around the forearm for 5 min). NMD was determined by measuring the maximum dilation of the brachial artery at the same point in response to sublingual administration of glyceryltrinitrate (75 µg) after a resting period of at least 15 min. In 8 subjects, NMD was not measured because of allergy to glyceryltrinitrate, hypotension, or glaucoma. FMD and NMD were calculated as follows:
FMD or NMD (%) =(maximum diameter-diameter at rest) * 100/diameter at rest. Impaired FMD was defined as <10.0%, which was reported as an independent predictor of coronary artery disease (12) .
Biochemical and physiological parameters
Blood and urine samples were obtained after overnight fasting. Plasma glucose levels
were measured with the glucose oxidase method. Glycated hemoglobin A1c (HbA1c) was determined by routine HPLC and a latex agglutination immunoassay and expressed as the National Glycohemoglobin Standardization Program equivalent value (13) . Homeostasis model assessment ratio (HOMA-R), which was calculated as fasting insulin (μU/ml) × fasting plasma glucose (FPG) (mg/dl)/405, was used to assess insulin sensitivity in the subjects without insulin (n=32). Serum creatinine, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured using an autoanalyzer (Hitachi 7450; Hitachi Co., Tokyo, Japan). Serum insulin and urinary albumin were determined by ECLIA (Roche Co., Tokyo, Japan) and TIA (Wako Co., Tokyo, Japan), respectively. eGFR, as a measure of renal function, was based on the equation
proposed by the Japanese Society of Nephrology (14) 
Statistical analysis
Continuous variables were expressed as the mean±SD. Median (limits of observed values) was used for the DM duration, HOMA-R, and urine albumin-to-creatinine ratio (UACR), because of their skewed distribution. Unpaired samples were analyzed non-parametrically using Mann-Whitney U test. Correlation coefficients were calculated by simple and multiple regression analyses. Simple regression analysis was performed using non-parametric Spearman rank correlation test. P-values < 0.05 were considered statistically significant. All data were analyzed using Stat View version 5.0 J (Abacus Concepts, Inc., Berkeley, CA).
Results
Clinical and biochemical profiles of the patients
The clinical and biochemical profiles of the type 2 DM patients (n=50) enrolled in the present study are shown in Table 1 . The mean age was 60.1±13.2 years, and 50% were male.
The median duration of DM was 9.0 years (range: 0.1 to 46.0 years). Among the patients, 14
patients (28%) were smokers. Hypertriglyceridemia is related in some part to the occurrence of insulin resistance (15) .
To further confirm the association of insulin resistance with MBPS in type 2 DM patients, we examined the correlation between HOMA-R, an established marker of insulin resistance, and MBPS in DM patients that were not undergoing insulin treatment. HOMA-R showed a significant and positive association with MBPS in type 2 DM patients (ρ=0.436, p=0.015) ( Figure 1B) , strongly suggesting the association between insulin resistance and MBPS. 
Multivariate association of MBPS with FMD, but not NMD in type 2 DM patients
To examine whether an independent association existed between increased MBPS and impaired FMD, multiple regression analyses were performed using model that included MBPS and HbA1c simultaneously, in addition to DM duration, gender, and LDL-C, and one of clinical variables, i.e., 24-hour SBP, UACR, smoking status, and treatment with ARB/ACEI because of their intertwining effect on each other (Table 3) . In model 1 which included MBPS and HbA1c simultaneously as independent variables, in addition to DM duration, gender, and LDL-C, MBPS (β=-0.309, p=0.028), but not HbA1c, was associated significantly in a negative manner with FMD. While MBPS retained its significant and independent association with FMD in any model 2-4, any of the other factors failed to associate with FMD. Of interest, in model 5 with ARB/ACEI treatment added as an independent variable, it was associated negatively with FMD, whereas MBPS was associated positively with FMD, suggesting that ARB/ACEI treatment protected against the development of endothelial dysfunction independent of MBPS.
Multiple regression analyses were performed to identify the factors that were associated independently with NMD in DM patients and showed that age (β=-0.334, p=0.042) and 24-hour SBP (β=-0.470, p=0.005), but not MBPS, were associated significantly in a negative manner with NMD, when MBPS and 24-hour SBP were included simultaneously as independent variables, in addition to age, gender, and LDL-C.
Discussion
In the present study, we demonstrated that higher HbA1c, as well as TG or HOMA-R, were significantly and independently associated with higher MBPS in patients with type 2 DM, and that MBPS was significantly and independently associated in a negative fashion with FMD, but not NMD. These data suggested that poor glycemic control or insulin resistance are associated with the occurrence of MBPS in type 2 DM patients, which might be associated with the development of endothelial dysfunction in those patients. MBPS is considered to result from increased activities of the sympathetic nervous system, the renin angiotensin system (RAS), and the hypothalamic pituitary adrenal (HPA) axis during the latter half of the sleep cycle (16) . Since insulin resistance is known to stimulate sympathetic activity by affecting the metabolism of adipocytokines, such as leptin (5), the association of TG and HOMA-R with MBPS might be explained through increased sympathetic activity by insulin resistance. Furthermore, it remains possible that insulinstimulated reabsorption of sodium at the renal tubule (17) might contribute to the development of MBPS. The activity of the HPA axis shows a clear circadian rhythm exhibiting a rapid rise during the latter half of the sleep with the highest levels in the early morning (18) , which occurs in parallel with the time-course change of BP (19) , suggesting the involvement of diurnal change of HPA axis in the generation of MBPS. It was reported that type 2 DM patients exhibit higher baseline levels of serum cortisol (20) . Although we did not monitor the diurnal change of serum cortisol in the present study, its serum level at 8:00am was significantly higher in those with insulin resistance than in those without.
Therefore, it is possible that insulin resistance might make the association with MBPS significant by it stimulatory effect on HPA axis at early morning.
Chronic hyperglycemia is reported to cause endothelial dysfunction by accumulating advanced glycation end (AGE)-products in the vascular wall (21), resulting in the development of vascular injury. In fact, hypertensive DM patients exhibit higher levels of plasma AGE-products than their non-hypertensive counterparts (22) .
Impaired FMD of the brachial artery, which is mainly caused by loss of endotheliumderived nitric oxide (NO) (23), has been established as a relevant marker for endothelial dysfunction (12) . MBPS appears to play the most important role in the development of endothelial dysfunction as reflected by the strongest association of MBPS with CVD risk (2).
Since acutely-increased mechanical stretch on endothelial cells, which might occur during MBPS, augment production of endothelium-derived superoxide, resulting in the inactivation of NO (24) . Indeed, it was reported that marked fluctuations in BP in sinoaortic-denervated rats significantly impaired endothelial function by reducing acetylcholine-induced NO release from aortic rings (25) . In the present study, HbA1c correlated significantly in a negative manner with FMD in univariate regression analyses, but not in multiple regression analyses including MBPS as independent variables, suggesting the intimate involvement of MBPS in the association of HbA1c and FMD. The previous study demonstrating that the association of blunted dip in BP during sleep with endothelial dysfunction in type 2 DM patients (26) might support our data suggesting MBPS as an important factor to accelerate vascular damage in type 2 DM patients.
Our study showed that MBPS was associated with impaired FMD, a marker for endothelium injury, but not NMD, a marker of vascular smooth muscle function (27) . Since it was reported that DM patients showed vascular injury more predominantly on endothelium than on arterial wall (28) The limitation of our study is, first, this study is a cross-sectional study and insufficient to disentangle potential relationships between poor glycemic control, insulin resistance and MBPS since HbA1c, HOMA-R and MBPS are measured at a single point. Second, ABPM is ideally conducted at home in a routine daily environment. In this study, ABPM was performed within several days after admission to the Hospital to avoid the inter-individual difference in the effect of resting condition of admission on diurnal BP variation. Third, since DM patients enrolled were treated with various drugs including anti-hypertensive drugs and statins, the effect of those treatments on MBPS could not be totally negated.
In conclusion, our results demonstrate that poor glycemic control and insulin resistance are significantly and positively associated with increased MBPS in patients with type 2 DM, and that MBPS is significantly and independently associated in a negative manner with FMD, but not NMD. Therefore, the present study raised the possibility that MBPS might be one of major target to prevent vascular damage in type 2 DM patients. UACR, urine albumin-to-creatinine ratio; ARB/ACEI, angiotensin receptor blocker or angiotensin-converting enzyme inhibitors.
* p< 0.05
